Literature DB >> 24416783

Association of cytokines in hepatitis E with pregnancy outcome.

Ashok Kumar, Salam Gyaneshwori Devi, Premashis Kar, Sarita Agarwal, Syed Akhtar Husain, Ram Kumar Gupta, Shashi Sharma.   

Abstract

AIMS: The aim of this study was to evaluate tumour necrosis factor-alpha (TNF-α), interleukin (IL)-6, interferon gamma (IFN-γ) and transforming growth factor-beta1 (TGF-β1) in hepatitis E infection during pregnancy and its relation with pregnancy outcome.
METHODS: A total of 272 pregnant and 219 non-pregnant women with hepatitis and 262 age and gestational age matched healthy pregnant women and 208 age matched, healthy non-pregnant women were evaluated on the basis of history, clinical examination, liver function profile. Serological tests of hepatitis A, B, C and E and cytokines using commercially available (ELISA) kits. The patients with hepatitis E were further evaluated for viral load by Real Time PCR. All these were followed till delivery for pregnancy outcome.
RESULTS: HEV viral load in acute viral hepatitis (AVH) and fulminant hepatic failure (FHF) of pregnant women were comparatively higher than non-pregnant women. Significantly higher levels of TNF-α, IL-6, IFN-γ and TGF-β1 were present in HEV infected pregnant women compared to non-pregnant women and controls. TNF-α, IL-6 and IFN-γ had significant positive correlation with viral load, serum bilirubin and prothrombin time in pregnant women. Higher levels of all four cytokines were found in pregnant women with HEV infection having adverse pregnancy outcome compared to that of pregnant women with non-HEV infection and controls.
CONCLUSION: In conclusion, severity of HEV infection and associated adverse pregnancy outcome might be mediated by cytokine in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24416783     DOI: 10.1016/j.cyto.2013.09.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  24 in total

1.  Enhancement of interferon induction by ORF3 product of hepatitis E virus.

Authors:  Yuchen Nan; Zexu Ma; Rong Wang; Ying Yu; Harilakshmi Kannan; Brenda Fredericksen; Yan-Jin Zhang
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 2.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

3.  A preliminary cost-effectiveness analysis of hepatitis E vaccination among pregnant women in epidemic regions.

Authors:  Yueyuan Zhao; Xuefeng Zhang; Fengcai Zhu; Hui Jin; Bei Wang
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

4.  Hepatitis E Virus.

Authors:  Georg Pauli; Martin Aepfelbacher; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Barbara Gärtner; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Uwe Schlenkrich; Volkmar Schottstedt; Rainer Seitz; Johanna Strobel; Hannelore Willkommen; Sally A Baylis
Journal:  Transfus Med Hemother       Date:  2015-06-01       Impact factor: 3.747

5.  Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.

Authors:  Nidhi Kaushik; Chandru Subramani; Saumya Anang; Rajagopalan Muthumohan; Baibaswata Nayak; C T Ranjith-Kumar; Milan Surjit
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

6.  Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.

Authors:  Yang Li; Peifa Yu; Amy L Kessler; Jingyi Shu; Xiaoyan Liu; Zhaochao Liang; Jiaye Liu; Yunlong Li; Pengfei Li; Ling Wang; Yining Wang; Zhongren Ma; Aixia Liu; Ling Wang; Marco J Bruno; Robert A de Man; Maikel P Peppelenbosch; Sonja I Buschow; Lin Wang; Yijin Wang; Qiuwei Pan
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

7.  Epidemiology, diagnosis, vaccines, and bibliometric analysis of the 100 top-cited studies on Hepatitis E virus.

Authors:  Tauseef Ahmad; Saima Nasir; Taha Hussein Musa; Saif Aldeen S AlRyalat; Muhammad Khan; Jin Hui
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

Review 8.  Mechanism of Cross-Species Transmission, Adaptive Evolution and Pathogenesis of Hepatitis E Virus.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Hiroaki Okamoto
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

Review 9.  Case-fatality risk of pregnant women with acute viral hepatitis type E: a systematic review and meta-analysis.

Authors:  H Jin; Y Zhao; X Zhang; B Wang; P Liu
Journal:  Epidemiol Infect       Date:  2016-03-04       Impact factor: 4.434

10.  TGF-β1 gene - 509C > T promoter polymorphism modulates TGF-β1 levels in hepatitis E patients.

Authors:  Sanjay B Rathod; Anuradha S Tripathy
Journal:  Meta Gene       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.